|
Pfizer’s Zithromax to Undergo FDA Review for Increased Death Risk
The FDA is reviewing a study that found patients treated with Pfizer’s antibiotic Zithromax may be at a slightly higher risk for cardiovascular death than those taking amoxicillin, Bayer Healthcare’s Cipro or no drug.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives